Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117105909A reveals a mild one-step synthesis for Lasmiditan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel anhydrous hydrolysis route for trityl olmesartan ensures high purity and yield, offering significant cost reduction in API manufacturing and supply chain stability.
Novel 8-oxa-3-azabicyclo[3.2.1]octane compounds for ATR inhibition. Enhanced solubility and metabolic stability for oncology drug development and supply chain optimization.
Discover a novel synthetic route for 3-aryl substituted pyrroles using copper-catalyzed oxidative ring contraction. Ideal for cost-effective API intermediate manufacturing.
Novel asymmetric hydrogenation route for sitagliptin intermediate CN106146340B. High ee value >99%, cost-effective manufacturing, reliable supply chain solution.
Patent CN104987323A details a cost-effective Dabigatran etexilate preparation method, offering significant supply chain stability and purity advantages for global pharmaceutical procurement.
Patent CN114920617B reveals a high-yield Lewis acid catalyzed route for polysubstituted naphthalenes, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel catalytic method ensures >98% purity for Vitamin A intermediates. Reduces purification steps and enhances supply chain stability for global buyers.
Novel copper-catalyzed synthesis of phenanthridone intermediates. High yield, scalable process for pharmaceutical manufacturing. Reliable supply chain partner.
Discover a novel synthesis route for trans-4-Boc-aminocyclohexanecarboxylic acid via patent CN113402428A. Achieve >95% stereoselectivity and streamlined manufacturing for peptide drugs.
Patent CN104447791B reveals a low-cost D-biotin preparation method. Discover supply chain advantages and high-purity manufacturing capabilities for global procurement.
Patent CN115448813B details a manganese-catalyzed route for Crizotinib intermediates. Achieves 95% ee with reduced costs and scalable mild conditions for global supply chains.
Patent CN115417895A reveals a safer microchannel hydrogenation process for cis-propenyl phosphoric acid, offering >97% selectivity and reduced catalyst costs for fosfomycin production.
Patent CN113387976A details a room-temperature synthesis of enol silyl ethers using nitroalkanes. This method offers significant cost reduction in pharmaceutical intermediate manufacturing.
Novel zinc-mediated reduction route for 4-aminonaphthalene-2,6-dicarboxylic acid offers high yield and cost efficiency for MOF and pharma applications.
Patent CN101475445B offers indium-promoted allylation. High yield, mild conditions, scalable for pharma intermediates.
Patent CN1228448C details a yeast-catalyzed route for (R)-2-halo-1-(substituted phenyl) ethanol, offering significant cost reduction in API manufacturing and superior stereocontrol.
Novel ticagrelor preparation method avoids hazardous chlorinating agents. Water-based steps reduce cost. Reliable supplier for scale-up and high purity.
Patent CN102167674A details a mild iridium-catalyzed method for synthesizing optically pure 3-aryl sulfur-substituted propenes, offering significant supply chain advantages.
Patent CN111471077B reveals a novel 2-deoxy-D-ribose derivative route achieving 8:1 beta-selectivity. Discover cost-effective, scalable manufacturing for oncology APIs.